Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Hims & Hers stock tumbles despite beating Q4 revenue estimates
In This Article:
Hims & Hers Health (HIMS) stock is dropping in extended hours upon the telehealth company's fourth quarter earnings release, topping revenue ($481.14 million vs. forecasts of $470.39 million) and total subscribers estimates (2.23 million vs. forecasts of 2.22 million.
Julie Hyman and Josh Lipton react to the earnings report.
To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here.
This post was written by Luke Carberry Mogan.
Related Videos
Terms and Privacy Policy